Key statistics
On Friday, HUTCHMED (China) Ltd (13:HKG) closed at 27.90, -19.83% below its 52-week high of 34.80, set on Oct 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 28.00 |
---|---|
High | 28.40 |
Low | 27.10 |
Bid | 27.85 |
Offer | 27.90 |
Previous close | 27.50 |
Average volume | 7.31m |
---|---|
Shares outstanding | 872.11m |
Free float | 501.29m |
P/E (TTM) | 81.04 |
Market cap | 23.98bn HKD |
EPS (TTM) | 0.3393 HKD |
Data delayed at least 15 minutes, as of Jul 18 2025 09:08 BST.
More ▼
- HUTCHMED to Announce 2025 Half-Year Results
- HUTCHMED to Announce 2025 Half-Year Financial Results
- Update on Joint Corporate Brokers in London
- Blocklisting Six Monthly Return
- China Approval based on Phase III SACHI Trial
- Total Voting Rights
- HUTCHMED Announces China Approval for ORPATHYS® in Combination with TAGRISSO® for the Treatment of Lung Cancer Patients with MET Amplification After Progression on First-Line EGFR Inhibitor Therapy
- Grant of Share Options and Awards under LTIP
- HUTCHMED and Innovent Announce NDA Acceptance
- HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
More ▼